{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:42:02Z","timestamp":1792114922139,"version":"4.4.0"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T00:00:00Z","timestamp":1304380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Poor susceptibility of\n                    <jats:italic>Cryptococcus neoformans<\/jats:italic>\n                    to fluconazole (FLC) is a matter of concern among clinicians in Africa. The emergence of resistance to FLC was recently reported in Kenya, but it is not known whether it is widespread. Thus, there is need for more antifungal drug susceptibility studies in Kenya. The aim of this study was to measure the\n                    <jats:italic>in vitro<\/jats:italic>\n                    antifungal drug susceptibilities of incident\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    isolates from acquired immunodeficiency syndrome patients in Kenya. Antifungal susceptibility testing was performed in 67\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    isolates by broth microdilution method as outlined in the Clinical and Laboratory Standards Institute document M27\u2010A3 using FLC, amphotericin B (AMB), voriconazole (VOR), ravuconazole (RAV) and flucytosine (5\u2010FC). Isolates were grown on\n                    <jats:sc>l<\/jats:sc>\n                    \u2010canavanine glycine bromothymol blue medium for serotype identification. Six per cent of the isolates were identified as\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    var.\n                    <jats:italic>gattii<\/jats:italic>\n                    serotype B or C and 94% as\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    var.\n                    <jats:italic>neoformans<\/jats:italic>\n                    . All isolates tested were susceptible to AMB, VOR and RAV (100%), and high susceptibilities were seen to FLC (97%), and 5\u2010FC (90%). Only 3% and 10% of the isolates\u2019 susceptibility to FLC and 5\u2010FC, respectively, was dose\u2010dependent or intermediate. These results demonstrate high susceptibilities of incident\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    isolates to FLC and AMB, antifungals used for treatment of cryptococcal meningitis in Kenya.\n                  <\/jats:p>","DOI":"10.1111\/j.1439-0507.2010.01946.x","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T04:59:47Z","timestamp":1304398787000},"source":"Crossref","is-referenced-by-count":28,"title":["Antifungal susceptibilities of\n                    <i>Cryptococcus neoformans<\/i>\n                    cerebrospinal fluid isolates from AIDS patients in Kenya"],"prefix":"10.1111","volume":"54","author":[{"given":"Rennatus","family":"Mdodo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Jaoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Baddley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam\u2010Colette","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Aban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Odera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the AIDS era\u2010100\u2003years after the discovery of Cryptococcus neoformans","volume":"8","author":"Mitchell TG","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280106d6a"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2006.01293.x"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.3.838-840.1999"},{"key":"e_1_2_9_6_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/9781555818241","volume-title":"Epidemiology, in Cryptococcus neoformans","author":"Casadevall A","year":"1998"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3065-3069.2001"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328322ffac"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldh043"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/27.4.698"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200205030-00009"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.5.2163-2167.2005"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh361"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/507895"},{"key":"e_1_2_9_15_2","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard","author":"Clinical and Laboratory Standards Institute","year":"2007"},{"key":"e_1_2_9_16_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.42.2.471","article-title":"In vitro comparative efficacy of voriconazole and itraconazole against fluconazole\u2010susceptible and \u2010resistant Cryptococcus neoformans isolates","volume":"42","author":"Nguyen MH","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.15.3.535-537.1982"},{"key":"e_1_2_9_18_2","first-page":"213","article-title":"High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions","volume":"257","author":"Kwon\u2010Chung KJ","year":"1984","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [A]"},{"key":"e_1_2_9_19_2","unstructured":"Direct Relief International: Diflucan Partnership Program[WWW document] 2001. URLhttp:\/\/www.diflucanpartnership.org\/en\/welcome\/[accessed on 25 January 2010]."},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2005.tb03707.x"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2010.01946.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.2010.01946.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:05:29Z","timestamp":1697241929000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2010.01946.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1439-0507.2010.01946.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2010.01946.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.11522958.12563056","asserted-by":"object"}]},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}